HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Yasuo Yoshioka Selected Research

Brachytherapy

7/2015Role of vaginal pallor reaction in predicting late vaginal stenosis after high-dose-rate brachytherapy in treatment-naive patients with cervical cancer.
7/2015Treatment results of image-guided high-dose-rate interstitial brachytherapy for pelvic recurrence of uterine cancer.
5/2015Estimation of the total rectal dose of radical external beam and intracavitary radiotherapy for uterine cervical cancer using the deformable image registration method.
3/2015Definitive radiotherapy for primary vaginal cancer: correlation between treatment patterns and recurrence rate.
1/2015Preliminary results of MRI-assisted high-dose-rate interstitial brachytherapy for uterine cervical cancer.
11/2014Dosimetry analyses comparing high-dose-rate brachytherapy, administered as monotherapy for localized prostate cancer, with stereotactic body radiation therapy simulated using CyberKnife.
10/2014High-dose-rate interstitial brachytherapy in combination with androgen deprivation therapy for prostate cancer: are high-risk patients good candidates?
8/2014Longitudinal analysis of late vaginal mucosal reactions after high-dose-rate brachytherapy in patients with gynecological cancer.
7/2014Impact of intraluminal brachytherapy on survival outcome for radiation therapy for unresectable biliary tract cancer: a propensity-score matched-pair analysis.
6/2014Role of novel risk classification method, Prostate Cancer Risk Index (PRIX) for clinically localized prostate cancer after high-dose-rate interstitial brachytherapy as monotherapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Yasuo Yoshioka Research Topics

Disease

63Neoplasms (Cancer)
07/2015 - 03/2002
26Prostatic Neoplasms (Prostate Cancer)
10/2015 - 03/2002
13Tongue Neoplasms (Tongue Neoplasm)
03/2014 - 03/2002
8Neoplasm Metastasis (Metastasis)
07/2015 - 01/2004
7Breast Neoplasms (Breast Cancer)
01/2015 - 05/2005
7Inflammation
08/2012 - 09/2003
5Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2015 - 11/2012
5Hemorrhage
11/2014 - 08/2008
5Carcinoma (Carcinomatosis)
11/2012 - 04/2009
5Infection
12/2010 - 07/2009
4Biliary Tract Neoplasms (Biliary Tract Cancer)
11/2015 - 01/2013
4Pathologic Constriction (Stenosis)
07/2015 - 09/2013
4Lung Neoplasms (Lung Cancer)
07/2015 - 02/2011
4Autoimmune Diseases (Autoimmune Disease)
02/2015 - 08/2009
4Mesothelioma
04/2012 - 09/2010
4Rheumatoid Arthritis
01/2010 - 01/2008
3Anaphylaxis (Anaphylactic Shock)
01/2015 - 08/2005
3Head and Neck Neoplasms (Head and Neck Cancer)
01/2015 - 01/2013
3Necrosis
08/2009 - 03/2004
2Hypersensitivity (Allergy)
01/2015 - 05/2009
2Atopic Dermatitis (Atopic Eczema)
01/2015 - 01/2012
2Telangiectasis (Telangiectasia)
08/2014 - 12/2013
2Rectal Neoplasms (Rectal Cancer)
04/2014 - 11/2006
2Erythema
12/2013 - 06/2011
2Crohn Disease (Crohn's Disease)
01/2010 - 06/2008
2Hepatitis
11/2008 - 01/2008
2Esophageal Neoplasms (Esophageal Cancer)
05/2005 - 03/2002
2Acute Kidney Injury (Acute Renal Failure)
03/2004 - 04/2003
1Premature Birth (Birth, Premature)
11/2015
1Uterine Neoplasms (Uterine Cancer)
07/2015
1Oropharyngeal Neoplasms
04/2015
1Vaginal Neoplasms (Cancer, Vaginal)
03/2015
1Adenocarcinoma
12/2014
1Erectile Dysfunction
11/2014
1Urinary Incontinence
11/2014
1Colonic Neoplasms (Colon Cancer)
07/2014
1Jaundice
07/2014
1Neutropenia
09/2013
1Leukopenia
09/2013
1Mouth Neoplasms (Oral Cancer)
01/2013
1Immune System Diseases (Immune Disorders)
10/2012
1Chondrosarcoma
09/2012

Drug/Important Bio-Agent (IBA)

12Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2015 - 03/2004
9Type I Tumor Necrosis Factor ReceptorsIBA
02/2015 - 01/2008
8AntigensIBA
01/2015 - 07/2004
6Proteins (Proteins, Gene)IBA
07/2015 - 02/2008
6antineoplaston A10 (A 10)IBA
01/2015 - 01/2011
5nedaplatinIBA
03/2015 - 12/2009
5Silicon Dioxide (Sand)FDA LinkGeneric
01/2015 - 09/2010
4Type II Tumor Necrosis Factor ReceptorsIBA
02/2015 - 03/2009
4EphA1 Receptor (Eph Receptor)IBA
01/2015 - 01/2011
4Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
09/2011 - 09/2007
3ProteomeIBA
07/2015 - 02/2011
3Carbon Nanotubes (Carbon Nanotube)IBA
01/2012 - 09/2010
3Thymidine KinaseIBA
09/2011 - 10/2007
3AntibodiesIBA
01/2010 - 07/2004
3PeptidesIBA
11/2007 - 01/2007
2DNA (Deoxyribonucleic Acid)IBA
04/2015 - 12/2013
2Cisplatin (Platino)FDA LinkGeneric
03/2015 - 04/2012
2Immunoglobulin E (IgE)IBA
01/2015 - 05/2009
2gemcitabineFDA Link
12/2014 - 01/2010
2Prostate-Specific Antigen (Semenogelase)IBA
11/2014 - 01/2006
2Messenger RNA (mRNA)IBA
07/2014 - 12/2013
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
04/2013 - 03/2010
2LuciferasesIBA
08/2012 - 01/2010
2CosmeticsIBA
08/2012 - 09/2010
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2010 - 10/2007
2Carbon MonoxideIBA
11/2007 - 04/2004
2Histamine (Histamine Dihydrochloride)FDA Link
07/2006 - 08/2005
1FullerenesIBA
11/2015
1hydroxide ionIBA
11/2015
1oxysterol receptorIBA
07/2015
1A 7 (A-7)IBA
05/2015
1GoldIBA
05/2015
1Hemoglobins (Hemoglobin)IBA
03/2015
1Immunoglobulin G (IgG)IBA
01/2015
1SiliconIBA
03/2014
1Lugol's solution (Lugol's iodine)IBA
01/2014
1Complementary DNA (cDNA)IBA
12/2013
1Paclitaxel (Taxol)FDA LinkGeneric
09/2013
1Carboplatin (JM8)FDA LinkGeneric
09/2013
1Lymphotoxin-alpha (Lymphotoxin)IBA
02/2013
1Peptide Initiation Factors (Initiation Factor)IBA
09/2012
1salubrinalIBA
09/2012
1Annexin A4IBA
04/2012
1Crocidolite Asbestos (Blue Asbestos)IBA
01/2012

Therapy/Procedure

48Brachytherapy
07/2015 - 03/2002
37Radiotherapy
11/2015 - 03/2002
13Drug Therapy (Chemotherapy)
01/2015 - 03/2003
5Hysterectomy
01/2015 - 11/2011
4Aftercare (After-Treatment)
07/2015 - 09/2013
3Immunotherapy
01/2010 - 11/2007
2Therapeutics
07/2015 - 01/2010
2Heterologous Transplantation (Xenotransplantation)
01/2015 - 09/2014
2Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
11/2014 - 04/2012
2Adjuvant Radiotherapy
03/2013 - 11/2011
1Intravenous Infusions
12/2014
1Lymph Node Excision (Lymph Node Dissection)
09/2013
1Anesthesia
05/2012
1Intradermal Injections
01/2012